Description
Seeking Men and Women 18-65 yeras old who have been diagnosed with schizophrenia or schizoaffective disorder who has not experienced a significant relief of symptoms in spite of being treated with one or more approved medicines for the treatment of their illness.
Overview
The main purpose of this study is to find out whether telmisartan targets and changes brain chemistry in patients with schizophrenia or schizoaffective disorder who have not experienced a significant relief of symptoms from current anti-psychotic medication.
What we're hoping for
This study will provide us knowledge that may help treat people with treatment resistant schizophrenia in the future.
Additional Information
ClinicalTrials.gov Identifier: Not Available